AIRE transcriptional condensates in central tolerance: a multiscale mechanistic perspective
-
By
-
Jiejie He
-
Weiwei Xue
-
Jun Zhang
-
Yan Li
-
July 15, 2026
Clinical Scorecard: Transcriptional Condensates of AIRE in Central Tolerance: A Comprehensive Mechanistic Overview
At a Glance
| Category | Detail |
|---|
| Condition | Central T-cell tolerance |
| Key Mechanisms | AIRE enables mTECs to express tissue-restricted antigens, coordinating chromatin recognition, enhancer recruitment, and transcriptional elongation. |
| Target Population | Individuals with autoimmune polyendocrine syndrome type 1 (APECED/APS-1) and related autoimmune conditions. |
| Care Setting | Research and clinical settings focused on immunology and autoimmune disorders. |
Key Highlights
- AIRE is crucial for the expression of tissue-restricted antigens in mTECs.
- Sparse TRA expression in mTECs reflects the low probability of chromatin reaching a permissive state.
- AIRE forms transcriptionally active condensates that influence gene expression dynamics.
- Pathogenic AIRE variants lead to autoimmune polyendocrine syndrome type 1.
- AIRE's function is linked to diverse mTEC subsets rather than a uniform population.
Guideline-Based Recommendations
Diagnosis
- Consider AIRE mutations in patients with autoimmune polyendocrine syndrome type 1.
Management
- Monitor for autoimmune manifestations in patients with AIRE-related disorders.
Monitoring & Follow-up
- Assess TRA expression levels in mTECs for understanding central tolerance mechanisms.
Risks
- Loss of AIRE function is associated with increased risk of autoimmune diseases.
Patient & Prescribing Data
Patients with AIRE mutations or related autoimmune conditions.
Understanding AIRE's role in TRA expression may inform therapeutic strategies for autoimmune disorders.
Clinical Best Practices
- Utilize genomic studies to identify AIRE-related mutations in patients.
- Incorporate single-cell analysis to assess TRA expression in mTECs.
Related Resources & Content
